BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19266083)

  • 1. KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA.
    Cheng F; Weidner-Glunde M; Varjosalo M; Rainio EM; Lehtonen A; Schulz TF; Koskinen PJ; Taipale J; Ojala PM
    PLoS Pathog; 2009 Mar; 5(3):e1000324. PubMed ID: 19266083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity.
    Bajaj BG; Verma SC; Lan K; Cotter MA; Woodman ZL; Robertson ES
    Virology; 2006 Jul; 351(1):18-28. PubMed ID: 16647097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY; West JT; Wood C
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
    Sun Z; Jha HC; Robertson ES
    J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
    Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
    J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
    Sarek G; Järviluoma A; Moore HM; Tojkander S; Vartia S; Biberfeld P; Laiho M; Ojala PM
    PLoS Pathog; 2010 Mar; 6(3):e1000818. PubMed ID: 20333249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.
    Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D
    J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
    Sun R; Liang D; Gao Y; Lan K
    J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tousled-like kinases modulate reactivation of gammaherpesviruses from latency.
    Dillon PJ; Gregory SM; Tamburro K; Sanders MK; Johnson GL; Raab-Traub N; Dittmer DP; Damania B
    Cell Host Microbe; 2013 Feb; 13(2):204-14. PubMed ID: 23414760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of KSHV Latency and Lytic Reactivation.
    Broussard G; Damania B
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
    Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
    PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
    Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.
    Singh VV; Dutta D; Ansari MA; Dutta S; Chandran B
    J Virol; 2014 Mar; 88(5):2821-34. PubMed ID: 24352470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF1α-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Singh RK; Bose D; Robertson ES
    J Virol; 2021 May; 95(12):. PubMed ID: 33789996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
    Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
    PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.